Omnicell (OMCL) Total Debt Growth (3y) (2019 - 2025)
Powered by 
Analysis
Omnicell (OMCL) Total Debt Growth (3y) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | -14.11% |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -32.37% |
| Dec 31, 2024 | -29.05% |
| Mar 31, 2022 | 79.85% |
| Dec 31, 2021 | 51.64% |
| Dec 31, 2019 | -41.84% |
| Sep 30, 2019 | -29.83% |
| Jun 30, 2019 | -30.22% |
| Mar 31, 2019 | -24.73% |